sarpogrelate has been researched along with Disc, Herniated in 4 studies
sarpogrelate: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty patients with sciatica due to L4-5 or L5-S1 disc herniation were randomly allocated to treatment with the 5-HT2A inhibitor (sarpogrelate 300 mg/day) or nonsteroidal antiinflammatory drugs (NSAIDs; diclofenac 75 mg/day)." | 5.11 | New treatment of lumbar disc herniation involving 5-hydroxytryptamine2A receptor inhibitor: a randomized controlled trial. ( Hashimoto, T; Kanayama, M; Oha, F; Shigenobu, K; Yamane, S, 2005) |
| "Sarpogrelate treatment significantly reduced mechanical allodynia on days 5 and 8 of administration." | 1.34 | Sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, attenuates neurogenic pain induced by nucleus pulposus in rats. ( Enyo, Y; Hashizume, H; Inomata, Y; Kawakami, M; Okada, M; Yoshida, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanayama, M | 2 |
| Hashimoto, T | 2 |
| Shigenobu, K | 2 |
| Yamane, S | 2 |
| Oha, F | 1 |
| Hashizume, H | 1 |
| Kawakami, M | 1 |
| Yoshida, M | 1 |
| Okada, M | 1 |
| Enyo, Y | 1 |
| Inomata, Y | 1 |
| Sekiguchi, M | 1 |
| Konno, S | 1 |
| Kikuchi, S | 1 |
1 trial available for sarpogrelate and Disc, Herniated
| Article | Year |
|---|---|
New treatment of lumbar disc herniation involving 5-hydroxytryptamine2A receptor inhibitor: a randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Autonomic Nerve Block; Diclofenac; Epidural Space; F | 2005 |
3 other studies available for sarpogrelate and Disc, Herniated
| Article | Year |
|---|---|
Efficacy of serotonin receptor blocker for symptomatic lumbar disc herniation.
Topics: Adult; Female; Humans; Hypesthesia; Intervertebral Disc Displacement; Low Back Pain; Magnetic Resona | 2003 |
Sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, attenuates neurogenic pain induced by nucleus pulposus in rats.
Topics: Animals; Intervertebral Disc; Intervertebral Disc Displacement; Lumbar Vertebrae; Pain Measurement; | 2007 |
The effects of a 5-HT2A receptor antagonist on blood flow in lumbar disc herniation: application of nucleus pulposus in a canine model.
Topics: Animals; Blood Vessels; Disease Models, Animal; Dogs; Female; Intervertebral Disc; Intervertebral Di | 2008 |